Combined abiraterone acetate plus prednisone, salvage prostate bed radiotherapy and LH-RH agonists (CARLHA-GEP12) in biochemically-relapsing prostate cancer patients following prostatectomy: A phase I study of the GETUG/GEP.
about
Combined abiraterone acetate plus prednisone, salvage prostate bed radiotherapy and LH-RH agonists (CARLHA-GEP12) in biochemically-relapsing prostate cancer patients following prostatectomy: A phase I study of the GETUG/GEP.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Combined abiraterone acetate p ...... hase I study of the GETUG/GEP.
@en
Combined abiraterone acetate p ...... hase I study of the GETUG/GEP.
@nl
type
label
Combined abiraterone acetate p ...... hase I study of the GETUG/GEP.
@en
Combined abiraterone acetate p ...... hase I study of the GETUG/GEP.
@nl
prefLabel
Combined abiraterone acetate p ...... hase I study of the GETUG/GEP.
@en
Combined abiraterone acetate p ...... hase I study of the GETUG/GEP.
@nl
P2093
P2860
P356
P1433
P1476
Combined abiraterone acetate p ...... hase I study of the GETUG/GEP.
@en
P2093
Clément Palpacuer
Céline Mahier-Ait Oukhatar
Emmanuel Rio
Gérard A Milano
Loic Campion
Mélanie Dore
Pascal Pommier
Séverine Racadot
P2860
P304
22147-22157
P356
10.18632/ONCOTARGET.25189
P407
P577
2018-04-24T00:00:00Z